SCHEMBL24607484

SCHEMBL24607484

COc1ccc2c(c1Br)n(C)c(=O)n2COCC[Si](C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.37
▸ GAA P10253 1/20 0.35
▸ EGFR P00533 1/20 0.33
▸ IGF1R P08069 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ FLT4 P35916 1/20 0.33
▸ KDR P35968 1/20 0.33
▸ FLT3 P36888 1/20 0.33
▸ EPHB4 P54760 1/20 0.33
▸ TEK Q02763 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GRM2 Q14416 2/20 0.32
▸ DGAT1 O75907 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ TRPC5 Q9UL62 2/20 0.31
▸ TP53 P04637 1/20 0.31
▸ MAPK1 P28482 1/20 0.30
▸ APOBEC3G Q9HC16 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24607798 0.86 NPC1 (0.38) NPC1DGAT1
SCHEMBL25337708 0.85 NPC1 (0.38) NPC1DGAT1ALDH1A1
SCHEMBL31129761 0.80 NPC1 (0.38) NPC1DGAT1
SCHEMBL31276144 0.80 NPC1 (0.40) NPC1DGAT1
SCHEMBL29502401 0.80 NPC1 (0.41) NPC1GAAEGFRIGF1RSRC
SCHEMBL13015496 0.80 NPC1 (0.41) NPC1GAAEGFRIGF1RSRC
SCHEMBL24668167 0.76 NPC1 (0.42) NPC1GAASMN1; SMN2GRM2DGAT1
SCHEMBL29729427 0.76 NPC1 (0.42) NPC1GAASMN1; SMN2GRM2DGAT1
SCHEMBL31276238 0.75 NPC1 (0.43) NPC1GAAEGFRIGF1RSRC
SCHEMBL30702016 0.75 NPC1 (0.34) NPC1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117715904-A CDK2 degrading agents and uses thereof 凯麦拉医疗公司 2024-03-15 — — CN disclosed
EP-4334307-A1 CDK2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-03-13 — — EP disclosed
EP-4271664-A1 IRAK DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-11-08 — — EP disclosed
CN-116867758-A IRAK degradation agents and uses thereof 凯麦拉医疗公司 2023-10-10 — — CN disclosed
WO-2022236058-A1 CDK2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-11-10 — — WO disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
WO-2022147465-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2022-07-07 — — WO disclosed
Send feedback